PharmaBlock Opens New R&D Facility in Pennsylvania

Published on: 

PharmaBlock has opened a new R&D facility in Pennsylvania, expanding its capacity to deliver GMP projects.

PharmaBlock, a contract development and manufacturing organization focused on innovative chemistry and low-carbon manufacturing, announced on March 27, 2023 the opening of its new R&D facility in West Chester, Pa. The facility will expand the company’s footprint in the United States and increase its capacity to delivery good manufacturing practice (GMP) projects to global partners.

The new site includes 30,000 ft2 of lab space and includes process R&D labs, GMP suites, clean rooms, and GMP analytical labs. The site also enables flow chemistry, micro-packed bed hydrogenation, and solid-state chemistry capabilities. The site joins the company’s existing facility in Hatfield, Pa., and is a crucial addition to enhancing the delivery of clinical-stage API projects, according to a company press release.


"We are excited to celebrate the grand opening of our new research facility, which represents a significant milestone for our company," said Jing Li, president of PharmaBlock, in the release. "This state-of-the-art facility will enable us to provide our clients with the highest quality research and development solutions, and we look forward to continuing to innovate and advance."
Source: PharmaBlock